Literature DB >> 2049103

ONO-5046, a novel inhibitor of human neutrophil elastase.

K Kawabata1, M Suzuki, M Sugitani, K Imaki, M Toda, T Miyamoto.   

Abstract

ONO-5046, N-[2-[4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino] aminoacetic acid, competitively inhibited human neutrophil elastase (IC50 = 0.044 microM, Ki = 0.2 microM). It also inhibited leukocyte elastase obtained from rabbit, rat, hamster and mouse. However, ONO-5046 did not inhibit trypsin, thrombin, plasmin, plasma kallikrein, pancreas kallikrein, chymotrypsin and cathepsin G even at 100 microM. In in vivo studies, ONO-5046 suppressed lung hemorrhage in hamster (ID50 = 82 micrograms/kg) by intratracheal administration and increase of skin capillary permeability in guinea pig (ID50 = 9.6 mg/kg) by intravenous administration, both of which were induced by human neutrophil elastase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049103     DOI: 10.1016/0006-291x(91)91862-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  88 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.

Authors:  Samira Saadoun; Patrick Waters; Claire MacDonald; B Anthony Bell; Angela Vincent; A S Verkman; Marios C Papadopoulos
Journal:  Ann Neurol       Date:  2012-02-28       Impact factor: 10.422

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy.

Authors:  Satoshi Ono; Hironori Tsujimoto; Shu-Ichi Hiraki; Risa Takahata; Akifumi Kimura; Manabu Kinoshita; Takashi Ichikura; Hidetaka Mochizuki
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.352

5.  Suppressive effects of sivelestat on interleukin 8 and TNF-α production from LPS-stimulated granulocytes in whole blood culture.

Authors:  Shigehiro Shibata; Gaku Takahashi; Nobuki Shioya; Katsuya Inada; Shigeatsu Endo
Journal:  J Anesth       Date:  2010-10-26       Impact factor: 2.078

6.  Alternative proteolytic processing of hepatocyte growth factor during wound repair.

Authors:  Nils Buchstein; Daniel Hoffmann; Hans Smola; Sabina Lang; Mats Paulsson; Catherin Niemann; Thomas Krieg; Sabine A Eming
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  A neutrophil elastase inhibitor, sivelestat, improved respiratory and cardiac function in pediatric cardiovascular surgery with cardiopulmonary bypass.

Authors:  Satoshi Toyama; Fumimaro Hatori; Ayako Shimizu; Toshio Takagi
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

8.  Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.

Authors:  Danmeng Luo; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2020-03-04       Impact factor: 4.345

9.  Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice.

Authors:  R E Young; M-B Voisin; S Wang; J Dangerfield; S Nourshargh
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

10.  Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.

Authors:  Monica Guma; Lisa Ronacher; Ru Liu-Bryan; Shinji Takai; Michael Karin; Maripat Corr
Journal:  Arthritis Rheum       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.